BioCentury | Oct 17, 2019
Emerging Company Profile

Parker Institute’s ArsenalBio launches with $85M to build cell engineering war chest

...in and partnered with TCR therapy company Tmunity Therapeutics Inc. and T cell imaging biotech ImaginAb Inc....
BioCentury | Oct 15, 2019
Product Development

ImaginAb, pharmas in precompetitive push for T cell imaging biomarker

...indicator that the best way to develop biomarkers for immuno-oncology is by committee. On Monday, ImaginAb Inc....
...its CD8 ImmunoPET technology. The pharmas will help design clinical trials and analytical methods for ImaginAb’s...
...and circulating tumor DNA (ctDNA) (see “Shared Burden” and “ctDNA Inches Toward New Applications” ). ImaginAb...
BioCentury | Mar 4, 2019
Company News

Management tracks: Astellas, Sanofi China, Zafgen

...development officer. She was SVP of development operations at Verastem Inc. (NASDAQ:VSTM). Immuno-oncology imaging company ImaginAb Inc....
...which Roche (SIX:ROG; OTCQX:RHHBY) acquired. Elizabeth S. Eaton, Staff Writer Astellas Pharma Inc. Constellation Pharmaceuticals Inc. DermTech Inc. Fusion Pharmaceuticals Inc. ImaginAb Inc. Leo...
BioCentury | Jan 3, 2019
Company News

Management tracks: Portola, Coherus

...of global pharmaceutical drug development at the Galderma subsidiary of Nestlé Skin Health (Lausanne, Switzerland). ImaginAb Inc....
...firm, Ascellna Life Science Group, where he is a president and founder. Elizabeth S. Eaton Coherus BioSciences Inc. ImaginAb Inc. Portola...
BioCentury | Oct 2, 2018
Politics & Policy

Nobel Prize goes to discoverers of checkpoint targets

...NASDAQ:JNCE) and Neon Therapeutics Inc. (NASDAQ:NTGN). He is on the scientific advisory boards (SABs) of ImaginAb Inc....
BioCentury | Feb 8, 2018
Company News

Management tracks: CRISPR, Arcturus

...Paul Kasian will be interim CEO as the company seeks Buccilli's replacement. Immuno-oncology imaging company ImaginAb Inc....
BioCentury | Jan 26, 2018
Finance

Tmunity’s A team

...Last year, the Parker Institute participated in an $8 million venture round for diagnostics company ImaginAb Inc....
BioCentury | Jan 18, 2016
Clinical News

IAB2M: Phase I/IIa data

...were presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco. ImaginAb Inc....
BioCentury | Nov 16, 2015
Company News

Eli Lilly, ImaginAb deal

...The companies partnered to study T cell-based immuno-oncology therapies. ImaginAb will conduct preclinical studies using IAB22M2C...
...terms, and ImaginAb did not respond to inquiries. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. ImaginAb Inc....
BioCentury | Nov 10, 2014
Financial News

Merieux Developpement financial update

...12 companies from 2010-14, including neurology company NeuroPhage Pharmaceuticals Inc. (Cambridge, Mass.) and diagnostics company ImaginAb Inc....
Items per page:
1 - 10 of 35
BioCentury | Oct 17, 2019
Emerging Company Profile

Parker Institute’s ArsenalBio launches with $85M to build cell engineering war chest

...in and partnered with TCR therapy company Tmunity Therapeutics Inc. and T cell imaging biotech ImaginAb Inc....
BioCentury | Oct 15, 2019
Product Development

ImaginAb, pharmas in precompetitive push for T cell imaging biomarker

...indicator that the best way to develop biomarkers for immuno-oncology is by committee. On Monday, ImaginAb Inc....
...its CD8 ImmunoPET technology. The pharmas will help design clinical trials and analytical methods for ImaginAb’s...
...and circulating tumor DNA (ctDNA) (see “Shared Burden” and “ctDNA Inches Toward New Applications” ). ImaginAb...
BioCentury | Mar 4, 2019
Company News

Management tracks: Astellas, Sanofi China, Zafgen

...development officer. She was SVP of development operations at Verastem Inc. (NASDAQ:VSTM). Immuno-oncology imaging company ImaginAb Inc....
...which Roche (SIX:ROG; OTCQX:RHHBY) acquired. Elizabeth S. Eaton, Staff Writer Astellas Pharma Inc. Constellation Pharmaceuticals Inc. DermTech Inc. Fusion Pharmaceuticals Inc. ImaginAb Inc. Leo...
BioCentury | Jan 3, 2019
Company News

Management tracks: Portola, Coherus

...of global pharmaceutical drug development at the Galderma subsidiary of Nestlé Skin Health (Lausanne, Switzerland). ImaginAb Inc....
...firm, Ascellna Life Science Group, where he is a president and founder. Elizabeth S. Eaton Coherus BioSciences Inc. ImaginAb Inc. Portola...
BioCentury | Oct 2, 2018
Politics & Policy

Nobel Prize goes to discoverers of checkpoint targets

...NASDAQ:JNCE) and Neon Therapeutics Inc. (NASDAQ:NTGN). He is on the scientific advisory boards (SABs) of ImaginAb Inc....
BioCentury | Feb 8, 2018
Company News

Management tracks: CRISPR, Arcturus

...Paul Kasian will be interim CEO as the company seeks Buccilli's replacement. Immuno-oncology imaging company ImaginAb Inc....
BioCentury | Jan 26, 2018
Finance

Tmunity’s A team

...Last year, the Parker Institute participated in an $8 million venture round for diagnostics company ImaginAb Inc....
BioCentury | Jan 18, 2016
Clinical News

IAB2M: Phase I/IIa data

...were presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco. ImaginAb Inc....
BioCentury | Nov 16, 2015
Company News

Eli Lilly, ImaginAb deal

...The companies partnered to study T cell-based immuno-oncology therapies. ImaginAb will conduct preclinical studies using IAB22M2C...
...terms, and ImaginAb did not respond to inquiries. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. ImaginAb Inc....
BioCentury | Nov 10, 2014
Financial News

Merieux Developpement financial update

...12 companies from 2010-14, including neurology company NeuroPhage Pharmaceuticals Inc. (Cambridge, Mass.) and diagnostics company ImaginAb Inc....
Items per page:
1 - 10 of 35